Home Healthcare Animal Health Pet DNA Testing Market

Pet DNA Testing Market Size, Share & Trends Analysis Report By Type (Dogs, Cats, Other Animals), By Sample (Blood, Saliva, Faecal, Others), By Test (Breed Profile, Genetic Diseases, Health and Wellness), By End-User (Pet Owners, Breeders, Veterinarians) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Pet DNA Testing Market Size & Growth Analysis

The global pet dna testing market size was valued at USD 484.04 million in 2025 and is projected to grow from USD 533.22 million in 2026 to USD 1156.37 million by 2034, registering a CAGR of 10.16% during the forecast period from 2026 to 2034. North America dominated the pet dna testing market with a market share of 43.12% in 2025.

The pet DNA testing market refers to the industry focused on genetic analysis services for companion animals, including dogs, cats, and other small or exotic pets, to provide insights into breed composition, hereditary disease risks, trait expression, and overall wellness indicators. These tests use biological samples such as saliva, blood, fecal matter, or other tissues to extract and analyze genetic material through laboratory sequencing and bioinformatic interpretation. The market encompasses direct-to-consumer test kits, veterinary-integrated genetic screening, and breeder-focused lineage verification services, enabling pet owners, veterinarians, and breeders to make informed decisions regarding health management, preventive care, breeding choices, and behavioral understanding. As demand for personalized pet care increases, the market continues to expand with broader test offerings, improved genomic databases, and growing adoption across various end-user groups.

Pet DNA Testing Market Size

Download a Free Sample To learn more about this report.

Type Insights

Dogs dominated the market with a share of 55.34% due to the wide adoption of breed identification and hereditary condition screening among dog owners. The segment benefits from high use of DNA kits for lineage confirmation, trait mapping, and detection of inherited risks in purebred and mixed-breed dogs. Growing participation in pet communities, competitions, and training programs further encourages routine use of genetic profiling, keeping this category in a leading position.

Cats are the fastest-growing segment with 11.12%, driven by rising attention toward feline health traits, breed verification, and screening of genetic disorders common in pedigree cats. Increased preference for indoor pets and growth of feline wellness subscriptions support strong momentum in this category.

Pet DNA Testing Market Size By Segments

Request Customizationto receive a tailored report.

Sample Insights

Saliva dominated the market with 56.74% as most consumer DNA kits rely on easy self-collection methods that do not require clinical involvement. Pet owners prefer saliva swabs for convenience, non-invasive sampling, and shorter turnaround times. The segment benefits from wide kit availability across online retail channels, enabling broad adoption of saliva-based testing in both urban and suburban households.

Blood is the fastest-growing segment with 11.32%, supported by rising interest in advanced genomic markers that require higher-quality DNA. Veterinary clinics increasingly conduct blood-based tests for deeper analysis of hereditary disorders and complex traits, contributing to stronger demand within clinical settings.

Test Insights

Breed profile dominated the market with 43.01%, supported by high consumer interest in ancestry breakdown, lineage confirmation, and identification of mixed-breed composition. The segment leads due to strong demand from households adopting rescued or crossbred animals where the genetic background is unknown. Breed-specific trait exploration and rising social media sharing of ancestry results reinforce the popularity of this category.

Health and wellness is the fastest-growing segment, with 11.44% as pet owners adopt proactive monitoring of genetic predispositions linked to long-term conditions. Veterinary recommendations and interest in lifestyle-related insights encourage rapid expansion of wellness-focused DNA panels that map risk markers, trait variations, and age-related genomic changes.

End-User Insights

Breeders dominated the market with 43.24%, driven by the need to verify lineage purity, manage hereditary traits, and maintain structured breeding programs. Breeders rely on DNA panels to monitor genetic diversity and ensure transparent records before pairing decisions. The segment remains strong due to the wide use of genomic data in pedigree certification and selection of breeding lines.

Pet owners are the fastest-growing segment with 11.66%, supported by rising awareness of genetic health insights and increasing preference for personalized pet care. Expansion of at-home test kits and interest in behavioral traits, disease risks, and ancestry profiles fuel steady adoption among first-time and experienced pet owners alike.

Pet DNA Testing Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America leads the pet DNA testing market with a 43.12% share due to widespread use of companion animal genetic screening, strong presence of commercial test kit providers, and high spending on pet wellness. The region benefits from a large population of dog and cat owners who actively seek breed identification, hereditary disease screening, and trait analysis services. Growth is influenced by expanding distribution of at-home saliva test kits, integration of genetic testing into veterinary workflows, and rising adoption of preventive pet healthcare. Companies continue to launch new panels that cover breed ancestry, health risk markers, and behavioural traits, encouraging wider consumer participation.

The U.S. market expands due to a large base of pet owners who purchase DNA test kits for health insights and breed discovery. Demand rises as veterinary networks incorporate genetic reports into care planning and breeders use DNA markers for lineage verification. Online retail channels offer broad kit availability, while subscription-based genomic updates shape recurring use of testing services. Public interest in pet wellness encourages higher spending on comprehensive genetic evaluations.

North America Pet DNA Testing Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

Asia Pacific is anticipated to register the fastest CAGR of 12.16% driven by several progresses as urban pet ownership increases, online commerce platforms expand test kit accessibility, and awareness of hereditary conditions grows among new pet adopters. Veterinary hospitals across the region are gradually integrating genetic testing into routine care to support early identification of breed-specific disorders. Rising use of digital pet health platforms encourages consumers to explore DNA-based insights covering traits, ancestry, and wellness.

India’s market develops as pet owners show growing interest in breed verification, inherited disease screening, and temperament traits. Expansion of veterinary clinics and pet diagnostic centers supports greater use of DNA-based assessments. E-commerce channels play a strong role, enabling convenient access to testing kits sourced from domestic and international brands. Increasing adoption of pedigree pets shapes the need for genetic confirmation and health-related genomic services.

Europe Market Insights

Europe advances as households continue to invest in pet care, and genetic health screening becomes more common among breeders and veterinary practitioners. Countries across the region are seeing growing preference for DNA-based reporting to confirm lineage accuracy, manage hereditary disorders, and map breed characteristics. Consumer interest in personalized pet profiles and digitally delivered genetic reports supports market expansion across both premium and mid-range testing categories.

Germany’s market grows due to the strong adoption of genomic tools by breeders, veterinary specialists, and pet owners who seek detailed lineage and health information. Demand is strengthened by widespread use of structured breeding programs that rely on DNA markers to maintain genetic standards. Availability of multi-panel test kits through clinics, online retailers, and pet stores supports the steady rise in testing volumes.

Middle East and Africa Market Insights

The Middle East and Africa region moves forward as pet ownership increases in urban households and veterinary facilities add genetic testing services to broaden diagnostic capabilities. Availability of imported DNA test kits is improving through regional distributors, enabling wider use across premium pet care segments. Rising participation in organized pet communities and shows fuels interest in breed validation and genetic health assessment.

The UAE market advances due to growing demand for breed authentication, health marker analysis, and pedigree verification. Expansion of veterinary centers and pet boarding facilities encourages the inclusion of DNA testing as part of broader pet wellness packages. The presence of international pet diagnostic brands in Dubai and Abu Dhabi enhances access to a wide range of genetic test offerings.

Latin America Market Insights

Latin America depicts progress as companion animal ownership expands in major cities and consumers adopt new tools for monitoring pet health. Veterinary clinics are increasingly offering genomic tests to support early detection of inherited disorders and better manage breed-related risks. Online platforms facilitate access to DNA test kits for ancestry mapping and screening of polygenic traits.

Brazil’s market strengthens as the country sees a rising number of households adopting pedigree and mixed-breed pets, prompting interest in ancestry tracing and inherited disease screening. Veterinary universities and large pet care providers promote awareness of genetic testing, contributing to higher test adoption. Domestic distributors and international suppliers continue to broaden product availability across urban retail and online channels.

Competitive Landscape

The pet DNA testing market is moderately fragmented, characterized by a mix of well-established genetic testing companies and a growing number of niche providers specializing in breed identification, hereditary disease screening, and wellness genomics.

PetDx: An emerging market player

  • PetDx, known for its advanced liquid biopsy genomic cancer screening for pets. It is rapidly gaining recognition as an innovative entrant in the pet DNA testing landscape, offering advanced genomic diagnostic solutions that go beyond traditional breed and health screening.

List of Key and Emerging Players in Pet DNA Testing Market

Embark Veterinary, Inc.
Wisdom Panel
DNA My Dog
Orivet Genetic Pet Care
Basepaws Inc.
Animal Genetics, Inc.
GenSol Diagnostics, LLC.
Neogen Corporation
Zoetis Services LLC.
Neogen Corporation
Macrogen, Inc.
com
MyDogDNA
MyCatDNA
Cision US Inc
EasyDNA
DNA Diagnostics Centre
BioPet Laboratories
Others

Key Industry Developments

June 2026
Embark Veterinary expanded its pet DNA testing portfolio by launching advanced genetic testing solutions featuring improved breed identification, health screening capabilities, and personalized pet wellness insights. The company focused on helping pet owners and veterinarians better understand genetic risks and improve preventive healthcare strategies.
April 2026
Wisdom Panel expanded its companion animal genomics portfolio by introducing enhanced DNA testing solutions with expanded genetic databases, improved accuracy, and advanced health screening features for dogs and cats. The company focused on supporting personalized pet care through genomic insights.
January 2026
Mars Petcare expanded its pet genomics initiatives through advancements in DNA-based pet health solutions. The company focused on improving genetic research, disease risk assessment, and personalized nutrition approaches for companion animals.
October 2025
Basepaws expanded its feline genetic testing portfolio by launching improved DNA testing solutions designed to provide cat owners with insights into breed characteristics, genetic health risks, and overall wellness indicators.

Report Scope

Segmentation

By Type 3
  • Dogs
  • Cats
  • Other Animals
By Sample 4
  • Blood
  • Saliva
  • Faecal
  • Others
By Test 3
  • Breed Profile
  • Genetic Diseases
  • Health and Wellness
By End-User 3
  • Pet Owners
  • Breeders
  • Veterinarians

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Embark Veterinary, Inc. · Wisdom Panel · DNA My Dog · Orivet Genetic Pet Care · Basepaws Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The pet dna testing market size is valued at USD 533.22 Million in 2026 and is projected to reach USD 1156.37 Million by 2034, at a CAGR of 10.16% during the forecast period 2026-2034.
North America dominated the market with a share of 43.12% in 2025.
The leading players in this market are Embark Veterinary, Inc., Wisdom Panel, DNA My Dog, Orivet Genetic Pet Care.
The pet dna testing market is projected to grow at a CAGR of 10.16% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now